BICARA THERAPEUTICS INC. - COMMON STOCK

12.53

10-二月-25 10:02:20

15 分钟延时

股票

+0.40

+3.30%

今日范围

12.07 - 12.53

ISIN

N/A

来源

NASDAQ

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium

27 1月 2025 08:00:15 条件 Nasdaq GlobeNewswire
Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

12 11月 2024 07:30:49 条件 Nasdaq GlobeNewswire
Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference

11 11月 2024 16:01:02 条件 Nasdaq GlobeNewswire
Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

16 9月 2024 16:01:00 条件 Nasdaq GlobeNewswire

<<
<
1
>

我同意 NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie 政策, 隐私政策 and 条款与条件.